Will David Sinclair be regularly taking a SGLT2 inhibitor (canagliflozin, empagliflozin) by the end of 2025?
Basic
2
Ṁ202026
50%
chance
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Related questions
Related questions
Will semaglutide be taken off FDA's drug shortage list in 2025?
62% chance
Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
58% chance
Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
54% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will an oral insulin pill be publicly available before the end of 2025?
24% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
38% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
17% chance